
Revelation Partners
Description
Revelation Partners is a specialized healthcare investment firm based in San Francisco, California, known for its dual approach to capital deployment. The firm primarily focuses on providing liquidity solutions and growth capital to leading companies within the expansive healthcare sector. Their investment scope is broad, encompassing various sub-sectors such as biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, and healthcare services, demonstrating a comprehensive understanding of the industry's diverse needs.
A significant part of Revelation Partners' strategy involves direct investments into growth-stage healthcare companies. These investments are often structured to provide liquidity to founders, early investors, and employees, enabling them to realize value while supporting the continued growth of the underlying businesses. The firm is recognized for its flexible investment approach, tailoring solutions to meet specific company and shareholder requirements. Their typical direct investment check sizes range from $10 million to $100 million, indicating a focus on substantial, impactful capital injections.
Beyond direct investments, Revelation Partners also allocates capital to healthcare-focused venture capital funds, operating as a fund of funds. This complementary strategy allows them to gain diversified exposure to emerging healthcare innovations and support the broader ecosystem of healthcare entrepreneurship. Since its inception, Revelation Partners has deployed over $2 billion across more than 100 healthcare companies and funds, underscoring their significant footprint and long-standing commitment to the healthcare investment landscape. This extensive track record highlights their expertise and deep network within the sector, positioning them as a key partner for healthcare innovators and investors alike.
Investor Profile
Revelation Partners has backed more than 49 startups, with 2 new investments in the last 12 months alone. The firm has led 5 rounds, about 10% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, Brazil, Ireland.
- Strong thematic focus on Health Care, Medical, Biotechnology.
- Typical check size: $10M – $100M.
Stage Focus
- Series B (24%)
- Series Unknown (20%)
- Series C (18%)
- Series E (14%)
- Series D (10%)
- Series F (4%)
- Series G (2%)
- Series A (2%)
- Convertible Note (2%)
- Private Equity (2%)
Country Focus
- United States (90%)
- Brazil (4%)
- Ireland (2%)
- United Kingdom (2%)
- Switzerland (2%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Medical Device
- Therapeutics
- Life Science
- Software
- Pharmaceutical
- Information Technology
- Hospital
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.